Ever Source Wealth Advisors, LLC Vaxcyte, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 508 shares of PCVX stock, worth $22,641. This represents 0.0% of its overall portfolio holdings.
Number of Shares
508
Previous 69
636.23%
Holding current value
$22,641
Previous $2,000
700.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PCVX
# of Institutions
324Shares Held
139MCall Options Held
229KPut Options Held
160K-
Janus Henderson Group PLC London, X014.7MShares$655 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$535 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA12MShares$533 Million8.5% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$443 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6MShares$267 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.64B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...